Shanghai Gentech News

shanghai gentech (688596): Performance meets expectations. Significant progress in OPEX business.

Core viewpoint: Performance meets expectations. The company published its third quarter report on October 30, achieving revenue of 3.501 billion yuan in Q1-3 of 2024, +45.23% year-on-year, with net income of 0.332 billion yuan, +22.58% year-on-year.

gf secNov 5 00:00

shanghai gentech (688596): In the third quarter of 2024, revenue performance continued to grow significantly, issuing convertible bonds to increase production capacity for electronic materials and pharmaceutical equipment.

Performance Brief The company disclosed its third quarter report for 2024 on October 31, 2024. In 3Q24, the company achieved revenue of 3.501 billion yuan, a year-on-year increase of +45.23%; achieving a net income attributable to the parent of 0.332 billion yuan, year-on-year

sinolinkOct 31 13:22

Zhengfan Technology: Report of Shanghai Zhengfan Technology Co., Ltd. Third Quarter 2024

SZSIOct 31 00:00 · Announcements

Shanghai Zhengfan Technology Co., Ltd. Report for the Third Quarter of 2024

SZSIOct 31 00:00 · Announcements

shanghai gentech (688596): Starting from high-purity process media system, layout of multi-grid products and application fields.

The core point of view is that the company continues to expand its products around the broad semiconductors, biomedical, and other homologous customers, expanding from process medium systems, MRO to GAS BOX, gases, advanced materials, and from CAPEX to OPEX business.

cscOct 20 07:56

Zhengfan Technology: Voluntary Disclosure Notice of Shanghai Zhengfan Technology Co., Ltd. on the performance forecast for the first three quarters of 2024

SZSIOct 16 00:00 · Announcements

Voluntary disclosure announcement of Shanghai Zhengfan Technology Co., Ltd. on the results forecast for the first three quarters of 2024

SZSIOct 16 00:00 · Announcements

Express News | Shanghai Gentech: The net income for the first three quarters of 2024 is expected to grow by 20% to 25%.

BreakingsOct 15 16:02

shanghai gentech (688596) 2024 third quarter performance forecast: Q3 performance exceeds market expectations, OPEX continues to realize growth logic.

Event Overview Shanghai Gentech released the 2024 third quarter performance forecast. The pace of confirmed orders is accelerating, with Q3 revenue performing better than market expectations. The company is expected to achieve a revenue of 338-361 billion yuan in 2024 Q1-3, a year-on-year +

huaxi SecuritiesOct 15 00:00

Express News | Shanghai Gentech: The "Suzhou Huaye Gas Manufacturing Co., Ltd. Phase I Technical Renovation Project" is officially put into operation.

BreakingsSep 8 18:00

Shanghai Gentech (688596): Order fulfillment, continuous strength in three major business sectors.

Investment Highlights: On August 30, Shanghai Gentech released the 2024 interim report. In the first half of 2024, the company achieved revenue of 1.852 billion yuan, a year-on-year increase of 37.78%; net income attributable to the parent company was 0.105 billion yuan, the same

德邦證券Sep 3 00:00

Shanghai Gentech (688596): Full order backlog, 1H24 non-GAAP net income attributable to parent company maintains high growth.

The company disclosed its 2024 interim report on August 29, achieving a revenue of 1.852 billion yuan in the first half of 2024, a year-on-year increase of 37.78%; achieving a net income attributable to the parent company of 0.105 billion yuan, a year-on-year decrease of 29.94%.

國金證券Aug 30 16:16

Shanghai Zhengfan Technology Co., Ltd. 2024 Semi-Annual Report

SZSIAug 30 00:00 · Announcements

Summary of the 2024 semi-annual report of Shanghai Zhengfan Technology Co., Ltd.

SZSIAug 30 00:00 · Announcements

Shanghai Gentech (688596.SH) released its semi-annual performance, with net income of 0.105 billion yuan, a year-on-year decrease of 29.94%.

shanghai gentech (688596.SH) disclosed its 2024 interim report, reporting that the company achieved revenue of 18.5...

Zhitong FinanceAug 29 20:50

Shanghai Gentech (688596.SH): the net income in the first half of the year was 0.105 billion yuan, a decrease of 29.94% year-on-year.

On August 29th, Shanghai Gentech (688596.SH) released its semi-annual report for 2024, with operating revenue of 1.852 billion yuan, a year-on-year increase of 37.78%; net income attributable to shareholders of the listed company was 0.105 billion yuan, a year-on-year decrease of 29.94%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.114 billion yuan, a year-on-year increase of 53.05%; basic earnings per share was 0.38 yuan.

Gelonghui FinanceAug 29 20:33

Express News | Shanghai Gentech: Net income in the first half of the year decreased by 29.94% year-on-year.

BreakingsAug 29 17:54

Express News | Shanghai Gentech plans to jointly invest with WendeChangwei in the semiconductor testing and measurement equipment business.

BreakingsAug 19 18:54

Express News | Shanghai Gentech: plans to invest $6.48 million and transfer the equity of Wende Semiconductor to Wende Changwei.

BreakingsAug 19 18:53

Shanghai Gentech (688596): Continuing to reach new highs with orders on hand, the net income attributable to the parent company in the first half of 2024 has increased by 50% year-on-year after deducting non-recurring gains and losses.

Event Overview: The company released its 2024 interim report forecast. Revenue achieved high-speed growth, and the backlog of orders continued to set new records. In H1 2024, the company expects to achieve revenue of 1.83-1.9 billion yuan, a year-on-year increase of +36%-+41%, and its

華西證券Jul 25 15:51